treatment of human natural killer ( nk ) cells with monoclonal antibodies of the igg isotype against nk cell-fcr ( igg ) increased lysis of most haematopoietic target cell lines with high or intermediate background nk susceptibility .
C0003241
antibodies
C0021017
isotype